Algo version: 0.98b
Putnam BioRevolution ETF is listed at the AMEX Exchange
Putnam BioRevolution ETF [SYNB]
AMEX Sector: Financial Services Industry:Asset Management

Is Putnam BioRevolution ETF stock a buy?

What Is The Conclusion?

Right now our advanced algorithms say:

Do the analyst corps agree?

Interesting Questions and Easy Answers!

Yes, Putnam BioRevolution ETF pays dividends. Last time was Monday 11th of December 2023 where the investors holding the stock on Wednesday 6th of December 2023 were paid $0.0211 per share. Over the last 1 times between 2023 and 2023, Putnam BioRevolution ETF has paid $0.0211 with an average of $0.02 per share.

Sorry, we do not have any analyst data for this ticker

We cannot find data for Putnam BioRevolution ETF 10 years ago, but if you had invested on Friday 30th of September 2022 when the price was $24.80, you would have made a profit of $4.79 per share or 19.31%

No, the average daily trading liquidity for Putnam BioRevolution ETF is $173 thousand. Trading in stocks with this little trading liquidity is very dangerous, and you can get into a situation where it will be hard to trade your stocks. In addition, these types of stocks usually have very high volatility.

Putnam BioRevolution ETF has no real debt, which is good in periods of high inflation. The company is still not profitable, and high inflation will make it harder to become profitable as costs increase and consumer spending decreases.

We have calculated the inflation risk for Putnam BioRevolution ETF to be medium [0.6 of 1]

US inflation for August 2024 was 0.19%. Over the last 12 months, the US inflation is 2.59%. The 10-year treasury yield that indicates the future interest level is currently 4.41 and is up 0.05 over the last 30 days.